-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
“Global Bioactive Coating Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global bioactive coating devices market report has been segmented on the basis of product type, application, material, end user, and region
Global Bioactive Coating Devices Market: Overview
Blood clotting creates on obstruction for the implantable device to perform and can also result in devices failure which is a major concern among orthopedic and other doctors. Bioactive compounds allow direct bonding of living tissues and osteoconduction. Continuous research and development activities are being carried out in order for the development of new implantable devices that have a thin film of bioactive molecules or drugs. These devices aid in preventing device failure and inflammation and also enhances the integration of the device with the tissues
Global Bioactive Coating Devices Market: Dynamics
Increasing adoption of various implantable medical devices, such as stents, heart valves, etc. in order to improve patients’ lives, coupled with rising adoption of bioactive coating in order to control the failure of implantable devices is a major factor expected to drive growth of the global bioactive coating devices market
In addition, increasing prevalence of chronic diseases such as systemic joint, cardiovascular diseases, etc. across the globe, rising government spending on development of healthcare infrastructure, and shifting focus on cell biology and reduction of antimicrobial contamination in order to restrict usage of antibiotics are among other factors expected to further boost the market growth.
However, high cost of R&D activities and lack of infrastructural facilities are some major factors expected to hamper growth of the global bioactive coating market. In addition, stringent government regulations related to product approval is another factor expected to further challenge the growth of the global market.
Increasing investment by major players for technological advancements and R&D activities are expected to create new opportunities in terms of revenue for players operating in the global market over the forecast period. In addition, growing public-private partnership for R&D activities and innovative product offerings is expected to further support growth of the global market to a certain extent.
Global Bioactive Coating Devices Market: Segment
Among the product type segments, the drug-eluting coating segment is expected to dominate in the target market over the forecast period
Among the application segments, the hospital segment is expected to witness moderate growth in the target market over the forecast period
Global Bioactive Coating Devices Market: Region
The market in North American is expected to dominate the global bioactive coating market and is expected to continue its dominance over the forecast period. This dominance can be attributed to well-developed healthcare infrastructure for R&D activities, increasing adoption of implants, favorable reimbursement policies, and the presence of major players operating in the countries in this region. In addition, growing merger and acquisition activities between regional and international players is expected to further support the market growth in this region.
The market in Asia Pacific is expected to witness faster growth, owing to changing regulatory scenario, and the increasing presence of major manufacturers in emerging economies in this region. In addition, increasing government expenditure on the development of healthcare infrastructure is resulting in technological advancements in medical devices by regional players.
Global Bioactive Coating Devices Market Segmentation:
Segmentation by product type
- Anti-microbial Coatings
- Hydrophilic Coatings
- Drug Eluting Coating
- Others (including Anti-thrombogenic Coatings)
Segmentation by application
- Stents
- Cardiac assist devices
- Electrosurgical tools
- Cochlear and ocular implants
- Mandrels and molds
- Catheters
- Others (Elastomeric seals, Needles and epidural probes, Medical electronics)
Segmentation by material
- Biological Materials
- Carbon-Based Materials
- Metals and Alloys
- Polymers and Synthetic
Segmentation by end user
- Hospital
- Diagnostics Centers
- Ambulatory Surgical Centers
- Clinics
Segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
- DSM Biomedical, Inc.
- Hydromer Inc.
- SurModics Inc.
- Biocoat Inc.
- AST Products Inc.
- Specialty Coatings Systems Inc.
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!